Prometrium Cost in Idaho 2026: Cash Prices, Insurance, and Compounding Options

What Does Prometrium Actually Cost in Idaho Right Now?

The AbbVie/Solvay manufacturer list price for Prometrium sits at $180 per month, but almost nobody in Idaho pays that figure. The average cash-pay price across Idaho retail pharmacies in 2026 is approximately $45 per month when a GoodRx, RxSaver, or similar pharmacy discount card is applied at checkout. That spread, $135 per month, exists entirely because of coupon programs and pharmacy-to-pharmacy variability in acquisition cost.

Retail Pharmacy Price Range Across Idaho

Prices are not uniform. A 30-capsule supply of Prometrium 200 mg at a Boise Walgreens, a Coeur d'Alene Walmart Pharmacy, and a Twin Falls independent pharmacy can vary by $20 to $40 even after a discount card is applied. Walmart and Costco pharmacies in Idaho tend to price generic micronized progesterone (the AB-rated generic manufactured by Virtus Pharmaceuticals and others) at the lowest end of the range. Generic micronized progesterone carries the same FDA-rated bioequivalence as brand Prometrium, and substitution is routine unless the prescriber writes "dispense as written."

Why the List Price Is Misleading

AbbVie's $180 wholesale acquisition cost reflects the brand price before any rebates, discount programs, or pharmacy-level negotiations. Patients who walk in without a coupon and pay cash at a full-price pharmacy may still see a sticker close to that figure. Always run your National Drug Code (NDC) through GoodRx, Blink Health, or the AbbVie/Solvay savings card portal before filling.

Compounded Micronized Progesterone: $25/Month in Idaho

Licensed 503A compounding pharmacies in Idaho may prepare micronized progesterone capsules, oral troches, or topical creams on a patient-specific, prescription basis. The going rate from Idaho-licensed 503A compounders is approximately $25 per month for oral micronized progesterone capsules. That price advantage comes with a trade-off: compounded products are not FDA-approved and have not undergone the same pharmacokinetic testing as Prometrium. The FDA's guidance on compounding makes this distinction clear, and the FDA compounding page explains what 503A status means for a pharmacy.

Idaho Medicaid Coverage for Prometrium

Idaho Medicaid does not cover Prometrium or compounded micronized progesterone for the indication of endometrial protection during menopausal hormone therapy as of 2026. This is a significant gap for low-income patients.

What the Idaho Medicaid PDL Says

The Idaho Medicaid Preferred Drug List (PDL) does not list micronized progesterone among covered progestogens for HRT. Medroxyprogesterone acetate (MPA) tablets, a synthetic progestin, has historically been the covered alternative on state Medicaid formularies across many states, including Idaho. The clinical distinction matters: the landmark PEPI trial (JAMA, 1995, N=875) demonstrated that micronized progesterone preserved HDL cholesterol benefits of estrogen therapy significantly better than MPA did, a finding that drove prescriber preference toward bioidentical progesterone. Despite that evidence, formulary decisions for Medicaid programs often prioritize acquisition cost over clinical differentiation.

Medicaid Prior Authorization: Worth Attempting

Some Idaho Medicaid providers have documented prior authorization approvals for Prometrium in patients with a documented adverse reaction to synthetic progestins. If your prescriber can document intolerance to MPA (mood changes, bleeding irregularities, or other adverse effects), a prior authorization request citing the PEPI trial data and the FDA-approved Prometrium label accessdata.fda.gov may succeed. The approval rate is not high, but the effort costs only time.

Medicaid Coverage for Other Prometrium Indications

Prometrium carries two FDA-approved indications: endometrial protection in postmenopausal women receiving estrogen, and secondary amenorrhea. Idaho Medicaid may cover secondary amenorrhea prescriptions under a different benefit category; confirm with your prescriber and the Idaho Department of Health and Welfare prior authorization line.

Private Insurance Coverage for Prometrium in Idaho

Coverage under commercial insurance plans sold in Idaho varies by plan tier, formulary design, and the specific indication on the prescription.

Blue Cross of Idaho, PacificSource, and SelectHealth Formularies

The three largest commercial carriers in Idaho as of 2026 place generic micronized progesterone on Tier 2 or Tier 3 of most formularies. Brand Prometrium, when it appears at all, sits on Tier 3 or Tier 4, meaning a typical copay lands between $40 and $85 per 30-day supply depending on the plan's cost-sharing structure. Generic substitution at the pharmacy counter drops most members to a Tier 1 or Tier 2 copay, often $10 to $30.

ACA Marketplace Plans and Preventive Benefit Status

Prometrium prescribed for endometrial protection does not qualify as a USPSTF A/B-rated preventive service, so the ACA's zero-cost preventive care mandate does not apply. However, some Idaho marketplace plans cover it under the general formulary benefit once a deductible is met. Plans purchased through Your Health Idaho (the state's ACA marketplace) each publish their Summary of Benefits and Coverage, which lists formulary tiers; check the specific plan's drug list before enrollment.

Employer-Sponsored Plans in Idaho

Large employer plans operating in Idaho are governed by ERISA, not state insurance mandates, which means Idaho's state-level coverage rules have limited reach over them. Many national employers use PBMs (pharmacy benefit managers) such as Express Scripts or CVS Caremark, and those PBMs' national formularies typically cover generic micronized progesterone at Tier 2. Calling the member services number on your insurance card to run a formulary check before the prescription is written takes about five minutes and avoids surprises.

Is Compounded Micronized Progesterone Legal in Idaho?

Yes. Compounded micronized progesterone prepared by a state-licensed 503A pharmacy is legal in Idaho when dispensed pursuant to a valid patient-specific prescription from a licensed prescriber. The Idaho Board of Pharmacy licenses and inspects 503A compounders under Idaho Code Title 54, Chapter 17.

503A vs. 503B: The Legal Boundary

A 503A pharmacy compounds for individual patients on a prescription-by-prescription basis and is regulated primarily by the state board of pharmacy, with FDA oversight of interstate distribution. A 503B outsourcing facility produces larger batches and is regulated directly by the FDA. Micronized progesterone from a 503A compounder in Boise or a compounding pharmacy anywhere in Idaho that ships to Idaho patients under a valid Rx is legal. Ordering bulk non-prescription progesterone compounds online without a prescription crosses into a different legal category and is not recommended.

Clinical Caveat on Compounded Progesterone

The FDA's 2019 statement on bioidentical hormone compounding notes that compounded preparations have not been tested for consistent absorption, sterility, or potency in the same way FDA-approved drugs have. Serum progesterone levels after oral micronized progesterone absorption are highly variable even with the brand product; that variability may be wider with compounded capsules if particle size or excipient composition differs from the Prometrium formulation. Monitoring serum progesterone levels a few weeks after starting any new compounded product is a reasonable clinical step.

Idaho Prescriber Requirements for Compounded Progesterone

Idaho prescribers must hold a valid DEA registration and Idaho state license. Progesterone is not a controlled substance, so DEA scheduling is not an issue here. The prescription must specify the exact formulation, strength, and quantity. Telehealth prescribers licensed in Idaho (or holding an interstate compact authorization) may write this prescription after a synchronous audio-video visit in most cases.

Getting Prometrium via Telehealth in Idaho

Telehealth prescribing of Prometrium is permitted in Idaho as of 2026. Idaho participates in the Interstate Medical Licensure Compact (IMLC), which allows physicians licensed in other compact states to practice telemedicine to Idaho patients if they hold an Idaho IMLC authorization.

What a Telehealth Visit for HRT Looks Like

A typical telehealth HRT visit in Idaho runs 20 to 40 minutes. The prescriber reviews the patient's menopause symptoms, uterine status (whether the uterus is intact, because women with a uterus require a progestogen to protect the endometrium when taking systemic estrogen), lab work, and personal and family history. Prometrium 200 mg at bedtime for 12 days per month (sequential) or 100 mg nightly (continuous) are the standard dosing schedules per the Menopause Society 2023 position statement.

Lab Work Before Starting

Most telehealth HRT providers in Idaho order a baseline estradiol, FSH, and comprehensive metabolic panel before prescribing. Some also request a thyroid panel (TSH, free T4) to exclude thyroid dysfunction as a driver of symptoms. Labs can be drawn at any LabCorp or Quest draw site in Idaho, with results typically available within 48 hours.

Prescribing Restrictions to Know

Idaho did not reinstate pre-pandemic telehealth restrictions on hormone prescribing as of this writing. The Ryan Haight Online Pharmacy Consumer Protection Act governs controlled substances; progesterone is not scheduled, so its online prescribing falls under general telemedicine and prescribing standards rather than DEA special-visit requirements. If you are also being prescribed a controlled-substance anxiolytic or sleep aid alongside HRT, different rules apply to that component.

How to Pay the Least for Prometrium in Idaho

Getting to the lowest possible price requires combining the right access pathway with the right discount tool. The steps are straightforward.

Step 1: Request Generic Micronized Progesterone

Ask your prescriber to write the prescription as "micronized progesterone 200 mg capsules" without specifying brand, or explicitly note "generic substitution permitted." The AB-rated generics are therapeutically equivalent to Prometrium per FDA bioequivalence standards.

Step 2: Run a GoodRx or RxSaver Comparison

Before going to the pharmacy, run a price comparison on GoodRx.com or RxSaver.com using your Idaho ZIP code. Prices at Costco Boise, Walmart Nampa, and Smith's Meridian can differ by $20 to $35 per fill on the same 30-capsule generic. Print or screenshot the lowest coupon and present it at the pharmacy counter.

Step 3: Apply the AbbVie Savings Card (for Brand Prometrium)

AbbVie offers a co-pay savings card for commercially insured and uninsured patients. The program has changed its terms over the years; check the current offer at the AbbVie patient assistance page before assuming specific savings amounts apply. As of early 2026, commercially insured patients using brand Prometrium may pay as little as $0 to $25 per fill depending on the current card terms. Idaho Medicaid enrollees are specifically excluded from manufacturer co-pay cards under federal anti-kickback rules.

Step 4: Consider a 90-Day Supply

Many Idaho pharmacies and mail-order pharmacies dispense a 90-day supply of generic micronized progesterone for roughly 2.5 times the 30-day price, saving approximately 15 to 20 percent over three individual monthly fills. Verify the 90-day pricing with your GoodRx search before assuming the discount applies.

Step 5: NeedyMeds and Manufacturer Patient Assistance Programs (PAP)

Patients with annual household income below approximately 400 percent of the federal poverty level may qualify for AbbVie's patient assistance program, which can provide Prometrium at no cost. NeedyMeds.org maintains an updated database of PAP eligibility criteria for Prometrium that is searchable by drug name.

Clinical Evidence Supporting Micronized Progesterone Over Synthetic Progestins

Understanding why prescribers prefer micronized progesterone over synthetic MPA helps patients advocate for their treatment choice when facing formulary pushback.

The PEPI Trial

The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial, published in JAMA in 1995 (N=875), randomly assigned postmenopausal women to one of five arms: placebo; conjugated equine estrogen (CEE) alone; CEE plus MPA cyclically; CEE plus MPA continuously; or CEE plus micronized progesterone cyclically. The micronized progesterone arm preserved the HDL cholesterol benefit of estrogen therapy significantly better than both MPA arms did, with the estrogen-only arm showing the largest HDL increase but carrying endometrial hyperplasia risk in women with a uterus. The PEPI investigators concluded that micronized progesterone combined with estrogen offered the most favorable cardiovascular risk-factor profile among the regimens studied that also protected the endometrium (JAMA 1995; 273:199-208).

Breast Cancer Signal Differences

Observational data from the French E3N cohort (N=80,377, published in Breast Cancer Research and Treatment, 2008) found that women using estrogen combined with micronized progesterone had a breast cancer relative risk similar to non-users (RR ~1.00), compared to women using estrogen with synthetic progestins who showed a meaningfully higher risk. That cohort study cannot establish causation and carries the usual confounding risks of observational research, but the finding has influenced clinical guideline language. The Menopause Society notes in its 2022 hormone therapy position statement that progestogen type may affect breast cancer risk.

FDA Label Indications

The Prometrium FDA-approved prescribing information states two indications: (1) protection of the endometrium from hyperplasia in postmenopausal women who are receiving conjugated estrogens, and (2) secondary amenorrhea. The label specifies 200 mg orally at bedtime for 12 days per 28-day cycle for the HRT indication, and 400 mg at bedtime for 10 days for secondary amenorrhea. Continuous combined regimens (100 mg nightly) are used off-label but are widely described in clinical practice guidelines.

Idaho-Specific Pharmacy Resources

Idaho has 44 counties served by a combination of chain pharmacies, independent pharmacies, and mail-order services. Rural patients in counties like Custer, Lemhi, or Valley may have limited local pharmacy options. Telehealth providers who prescribe Prometrium can send the prescription to any in-state or mail-order pharmacy the patient designates, including nationwide mail-order options like Amazon Pharmacy and Costco Mail Order.

Amazon Pharmacy in particular lists generic micronized progesterone with transparent per-unit pricing and a built-in discount card (RxPass membership offers flat-fee generics). Idaho law does not restrict mail-order delivery of non-controlled hormone medications.

Monitoring and Follow-Up Once You Start Prometrium in Idaho

Starting Prometrium is not a set-and-forget event. The standard follow-up schedule from most menopause specialists includes a check-in at 6 to 12 weeks to assess bleeding patterns, mood changes (progesterone has GABAergic sedating effects at the 200 mg dose), and symptom control, followed by annual review.

Endometrial Safety Monitoring

Women taking sequential Prometrium (12 days per month) should expect a withdrawal bleed toward the end of each cycle. Unexpected bleeding outside that window, or any bleeding in a woman using continuous-combined HRT who has been amenorrheic for more than 12 months, warrants endometrial biopsy evaluation. The American College of Obstetricians and Gynecologists (ACOG) recommends evaluation of unscheduled postmenopausal bleeding regardless of progestogen type.

Driving and Sedation Warning

Prometrium 200 mg taken at bedtime can cause significant next-morning sedation in some patients, a pharmacologic effect related to progesterone's conversion to allopregnanolone, a positive GABA-A modulator. Patients who notice residual sedation should avoid driving until the effect is characterized. Splitting the dose or switching to the 100 mg continuous regimen under prescriber guidance may reduce this effect.

Serum Progesterone Testing

Oral micronized progesterone produces a large first-pass hepatic metabolism effect, meaning serum progesterone levels drawn a few hours after the dose can be elevated but trough levels (drawn in the morning before the next dose) may be low. Some clinicians prefer to check a mid-luteal serum progesterone or a progesterone metabolite panel at a laboratory like ZRT (available by mail to Idaho patients) to confirm adequate tissue exposure. This is not a requirement in most guidelines but provides reassurance for patients concerned about endometrial protection.